Recruiting Scleroderma Studies in New Orleans
Sildenafil for Early Pulmonary Vascular Disease in Scleroderma
This is a Phase II randomized, double-blind, placebo-controlled trial of sildenafil in men and women with Scleroderma with mildly elevated pulmonary pressures (SSc-MEP) to determine whether sildenafil...
Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
This is a 2-Part study with Part A, a double-blind, randomized, placebo-controlled, PoC study to evaluate the efficacy, safety, and tolerability of efzofitimod in patients with SSc-ILD. The primary ob...
About Scleroderma Clinical Trials in New Orleans
Scleroderma is an autoimmune connective tissue disease characterized by hardening and tightening of the skin and connective tissues. Systemic sclerosis can also affect internal organs including lungs, kidneys, and heart. Treatment is directed at specific symptoms and organ involvement.
There are currently 2 scleroderma clinical trials recruiting participants in New Orleans, LA. These studies are seeking a combined 55 participants. Research is being sponsored by Johns Hopkins University, aTyr Pharma, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Scleroderma Clinical Trials in New Orleans — FAQ
Are there scleroderma clinical trials in New Orleans?
Yes, there are 2 scleroderma clinical trials currently recruiting in New Orleans, LA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in New Orleans?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the New Orleans research site will contact you about next steps.
Are clinical trials in New Orleans free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many New Orleans studies also compensate for your time and travel.
What scleroderma treatments are being tested?
The 2 active trials in New Orleans are testing new therapies including novel drugs, biologics, and treatment approaches for scleroderma.
Data updated March 2, 2026 from ClinicalTrials.gov